Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy.
Ohno, Yoshiyuki
Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy. [electronic resource] - International journal of clinical pharmacy Dec 2014 - 1134-7 p. digital
Publication Type: Case Reports; Journal Article
2210-7711
10.1007/s11096-014-0022-y doi
Anticoagulants--adverse effects
Antiemetics--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Aprepitant
Drug Interactions--physiology
Female
Humans
International Normalized Ratio--trends
Male
Middle Aged
Morpholines--adverse effects
Warfarin--adverse effects
Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy. [electronic resource] - International journal of clinical pharmacy Dec 2014 - 1134-7 p. digital
Publication Type: Case Reports; Journal Article
2210-7711
10.1007/s11096-014-0022-y doi
Anticoagulants--adverse effects
Antiemetics--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Aprepitant
Drug Interactions--physiology
Female
Humans
International Normalized Ratio--trends
Male
Middle Aged
Morpholines--adverse effects
Warfarin--adverse effects